Celator Pharmaceuticals Inc
CIK 0001327467
Revenue (TTM)
—
Q1 May 2016
Net Income (TTM)
−$20.44M
−14.3% YoY
Q1 May 2016
EPS Diluted (TTM)
—
Q1 May 2016
Gross Margin
—
Q1 May 2016
Operating Margin
—
Q1 May 2016
Net Margin
—
Q1 May 2016
Free Cash Flow (TTM)
—
Q1 May 2016
Cash
$67.54M
Q1 May 2016
Total Debt
$13.27M
Q1 May 2016
Shares Outstanding
42.47M sh
Q1 May 2016
Revenue & Net Income
Revenue Growth (YoY)
No data available for this metric.